Ramage D, Grant D, Timms R
Nat Commun. 2025; 16(1):1511.
PMID: 39929834
PMC: 11811203.
DOI: 10.1038/s41467-025-56782-1.
Neira J, Rizzuti B, Palomino-Schatzlein M, Rejas V, Abian O, Velazquez-Campoy A
Protein Sci. 2025; 34(2):e70033.
PMID: 39840810
PMC: 11751894.
DOI: 10.1002/pro.70033.
Morgan D, McDougall L, Knuhtsen A, Buetow L, Steven C, Shepperson O
RSC Chem Biol. 2025; 6(3):394-403.
PMID: 39830683
PMC: 11741006.
DOI: 10.1039/d4cb00288a.
Koolivand Z, Bahreini F, Rayzan E, Rezaei N
Heliyon. 2025; 11(1):e41355.
PMID: 39811307
PMC: 11730532.
DOI: 10.1016/j.heliyon.2024.e41355.
Wang W, Du Y, Datta S, Fowler J, Sang H, Albadari N
Genes Dis. 2025; 12(2):101156.
PMID: 39802403
PMC: 11719324.
DOI: 10.1016/j.gendis.2023.101156.
Lethal clinical outcome and chemotherapy and immunotherapy resistance in patients with urothelial carcinoma with MDM2 amplification or overexpression.
Jin K, Ding Y, Xu J, Liu Z, Zeng H, Su X
J Immunother Cancer. 2025; 13(1.
PMID: 39762080
PMC: 11749520.
DOI: 10.1136/jitc-2024-010964.
Involvement of the ubiquitin-proteasome system in the regulation of the tumor microenvironment and progression.
Huang Y, Gao Y, Lin Z, Miao H
Genes Dis. 2025; 12(2):101240.
PMID: 39759114
PMC: 11697063.
DOI: 10.1016/j.gendis.2024.101240.
Tumor hypoxia evidences the differential regulation of Mdm2-p53 axis by PTEN in tumor derived vs. normal endothelial cells.
Wilkus-Adamczyk K, Brodaczewska K, Kieda C
Sci Rep. 2024; 14(1):31747.
PMID: 39738367
PMC: 11686244.
DOI: 10.1038/s41598-024-82638-7.
Targeting liposarcoma: unveiling molecular pathways and therapeutic opportunities.
Liu H, Wang X, Liu L, Yan B, Qiu F, Zhou B
Front Oncol. 2024; 14:1484027.
PMID: 39723387
PMC: 11668776.
DOI: 10.3389/fonc.2024.1484027.
Unraveling the Guardian: p53's Multifaceted Role in the DNA Damage Response and Tumor Treatment Strategies.
Zhang H, Xu J, Long Y, Maimaitijiang A, Su Z, Li W
Int J Mol Sci. 2024; 25(23).
PMID: 39684639
PMC: 11641486.
DOI: 10.3390/ijms252312928.
New Synthetic Analogs of Natural 5Z,9Z-Dienoic Acids-Hybrid Molecules Based on Oleanolic Acid: Synthesis and Study of Antitumor Activity.
Tuktarova R, Dzhemileva L, Dzhemilev U, Dyakonov V
Cancers (Basel). 2024; 16(23).
PMID: 39682082
PMC: 11640419.
DOI: 10.3390/cancers16233893.
Role of artificial intelligence in cancer detection using protein p53: A Review.
Patil M, Bihari A
Mol Biol Rep. 2024; 52(1):46.
PMID: 39658610
DOI: 10.1007/s11033-024-10051-4.
A structure-based virtual screening identifies a novel MDM2 antagonist in the activation of the p53 signaling and inhibition of tumor growth.
Hu Q, Li L, Li Y, Zhang H, Deng T, Liu Y
Acta Pharmacol Sin. 2024; 46(3):740-750.
PMID: 39384887
PMC: 11845602.
DOI: 10.1038/s41401-024-01394-6.
Cellular origin and clonal evolution of human dedifferentiated liposarcoma.
Gruel N, Quignot C, Lesage L, El Zein S, Bonvalot S, Tzanis D
Nat Commun. 2024; 15(1):7941.
PMID: 39266532
PMC: 11393420.
DOI: 10.1038/s41467-024-52067-1.
MDM2 inhibitors in cancer immunotherapy: Current status and perspective.
Zeng Q, Zeng S, Dai X, Ding Y, Huang C, Ruan R
Genes Dis. 2024; 11(6):101279.
PMID: 39263534
PMC: 11388719.
DOI: 10.1016/j.gendis.2024.101279.
Protein ubiquitination in ovarian cancer immunotherapy: The progress and therapeutic strategy.
Guo H, Wei J, Zhang Y, Wang L, Wan J, Wang W
Genes Dis. 2024; 11(6):101158.
PMID: 39253578
PMC: 11382211.
DOI: 10.1016/j.gendis.2023.101158.
An MDM2 degrader shows potent cytotoxicity to MDM2-overexpressing acute lymphoblastic leukemia cells with minimal toxicity to normal cells/tissues.
Liu T, Gu L, Mui A, Wu Z, Albadari N, Li W
Cancer Lett. 2024; 598:217126.
PMID: 39053726
PMC: 11515855.
DOI: 10.1016/j.canlet.2024.217126.
Rational design of small-sized peptidomimetic inhibitors disrupting protein-protein interaction.
Wang J, Zheng P, Yu J, Yang X, Zhang J
RSC Med Chem. 2024; 15(7):2212-2225.
PMID: 39026653
PMC: 11253864.
DOI: 10.1039/d4md00202d.
Canonical and non-canonical functions of p53 isoforms: potentiating the complexity of tumor development and therapy resistance.
Guo Y, Wu H, Wiesmuller L, Chen M
Cell Death Dis. 2024; 15(6):412.
PMID: 38866752
PMC: 11169513.
DOI: 10.1038/s41419-024-06783-7.
α-Hydrazino Acid Insertion Governs Peptide Organization in Solution by Local Structure Ordering.
Kavcic L, Ilc G, Wang B, Vlahovicek-Kahlina K, Jeric I, Plavec J
ACS Omega. 2024; 9(20):22175-22185.
PMID: 38799301
PMC: 11112695.
DOI: 10.1021/acsomega.4c00804.